U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 5076029

Helium-Filled Sun Shade

A helium-filled sun shade for protecting individuals engaged in outdoor activities.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 514/222.8 - Polycyclo ring system having the six-membered hetero ring as one of the cyclos


Subclass of Class 514 - Drug, bio-affecting and body treating compositions
Definition: Subject matter in which the six-membered hetero ring is
No. of applications: 36
Last issue date: 05/03/2012


Application No.Application TitleIssue Date
20120107273NEW PIPERAZINE COMPOUND AND USE THEREOF AS A HCV POLYMERASE INHIBITOR
The present invention relates to a compound represented by the following formula [I]

wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof...

05/03/2012
20120035160NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE
Compounds derived from imidazo[4,5-c][1,2,6]thiadiazine 2,2-dioxides, for use as a drug or pharmaceutical composition for treatment of parasitic diseases, preferably of diseases caused by parasites of the Trypanosoma genus, and more preferably for treatment of th...
02/09/2012
20110319378PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER
The present invention provides MDM2 inhibitor compounds of Formula I,

    • wherein the variab...
12/29/2011
20110306601PHARMACOLOGICAL MODULATION OF POSITIVE AMPA RECEPTOR MODULATOR EFFECTS ON NEUROTROPHIN EXPRESSION
Antagonists of group 1 metabotropic glutamate receptors (mGluR) potentiate the effect of positive AMPA receptor modulators on neurotrophin expression, such as brain-derived neurotrophic factor (BDNF). The findings described herein suggest a combinatorial approach for dr...
12/15/2011
20110257162HIV INTEGRASE INHIBITORS
Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication:

wherein m, n, X, R1, R2, R3, R4, R5, R6, R7

10/20/2011
20110224155MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH
The present invention includes methods for identifying modifiers of chemosensory receptors and their ligands, e.g., by determining whether a test entity is suitable to interact with one or more interacting sites within the Venus flytrap domains of the chemosensory recep...
09/15/2011
20110207723NOVEL FUSED AMINODIHYDROTHIAZINE DERIVATIVE
A compound represented by the general formula (I):

a pharmaceutically acceptable salt thereof, or a solvate of the compound or salt has an Aβ production inhibitory activity or BACE 1 inhibitory activity, and...

08/25/2011
20110110948BENZENESULFONYL-CHROMANE, THIOCHROMANE, TETRAHYDRONAPHTHALENE AND RELATED GAMMA SECRETASE INHIBITORS
Disclosed are novel gamma secretase inhibitors of the formula (I): or a pharmaceutically acceptable salt, solvate, or ester thereof, wherein L1, n, X, Ar, Y, Z, Q, and Q1 are as defined herein. Also disclosed are methods for inhibiting gamma secret...
05/12/2011
20110112079PHOSPHODIESTERASE INHIBITORS
The invention related to compounds for formula I useful for inhibiting phosphodiesterase-4....
05/12/2011
20110071141Pesticidial Condensed-Ring Aryl Compounds
Condensed-ring aryl compounds of formula (I) and use of the same as a agrochemical for controlling noxious organisms wherein (X)mQ, A, R1, (Y)n and the grouping —W1—W2—W3—W4— are as d...
03/24/2011
20100305109POTASSIUM CHANNEL MODULATORS
Disclosed herein are KCNQ potassium channels modulators of formula (I)

wherein ring G1, X, R1, and R2 are as defined in the specification. Compositions comprising such compoun...

12/02/2010
201002677034-Amino-1,2,3-benzoxathiazine-Derivatives as Pesticides
The present invention relates to novel benzoxathiazine derivatives of the formula (I)

in which R1, R2, R3, R4, R5 and R6 are each as defined i...

10/21/2010
20100261714INHIBITORS OF HIV REPLICATION
Compounds of formula (I):

wherein R1, R2, A1, A2, A3, A4, X and Y are as defined herein, are useful as inhibitors of HIV replication....

10/14/2010
20100261641SPIRO-PIPERIDINE COMPOUNDS AND MEDICINAL USE THEREOF
The present invention relates to a spiro-piperidine compound represented by formula (I):

wherein R1 represents hydrogen, an aliphatic hydrocarbon group which may have a substituent(s) or a cyclic g...

10/14/2010
20100234350PLATELET ADP RECEPTOR INHIBITORS
Novel compounds of formulae (I) to (VIII), which more particularly include sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives which a...
09/16/2010
20100215620THE CO-CULTURE METHOD OF SPHINGOMONAS SP. BACTERIAL STRAIN AND ASPERGILLUS SP. FUNGUS STRAIN, NEW ANTI-CANCER AND ANTIBIOTIC GLIONITRINS DERIVED FROM THIS CO-CULTURE METHOD, AND PHARMACEUTICAL COMPOSITION CONTAINING GLIONITRINS OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS AN ACTIVE INGREDIENT
The present invention relates to a co-culture method of Sphingomonas sp. bacterial strain and Aspergillus sp. fungus strain, in which the novel Sphingomonas sp. bacterial strain KMK-001 is cultured in a liquid medium and the novel Aspergillus
08/26/2010
20100190774INHIBITORS OF C-MET AND USES THEREOF
The present invention provides compounds useful as inhibitors of c-Met tyrosine kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various proli...
07/29/2010
201001907783,4-DIHYDROBENZO[1,2,3]THIADIAZINE-1,1-DIOXIDE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, MEDICAMENTS CONTAINING SAID DERIVATIVES AND THEIR USE
The present invention is related to new 3,4-dihydroberizo[1,2,3]thiadiazine-1,1-dioxide derivatives of the Formula (I), medicaments containing said new compounds, process for the preparation thereof and the use of said derivatives in the medicine. The compounds accordin...
07/29/2010
20100184749BENZOTHIADIAZINE COMPOUNDS AND THEIR USE
Chemokine receptor antagonists, in particular, compounds of Formula (I) that act as antagonists of the chemokine CCR2 receptor, including pharmaceutical compositions and uses thereof to treat or prevent diseases associated with monocyte accumulation, lymphocyte accumula...
07/22/2010
20100168087BENZO[1,2,3]THIADIAZINE DERIVATES
The present invention relates to new benzo[1,2,3]thiadiazine-1,1-dioxide derivatives of the general Formula (I), medicaments containing such compounds and the use thereof in the medicine. Benzo[1,2,3]thiadiazine-1,1-dioxide derivatives of the general Formula (I) are sui...
07/01/2010
201000347735,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS
The invention is directed to 5,6-dihydro-1H-pyridin-2-one compounds and pharmaceutical compositions containing such compounds that are useful in treating infections by hepatitis C virus....
02/11/2010
20090306057[1,2,4]THIADIAZINE 1,1-DIOXIDE COMPOUNDS
The invention is directed to [1,2,4]thiadiazine 1,1-dioxide compounds and pharmaceutical compositions containing such compounds that are useful in treating infections by hepatitis C virus....
12/10/2009
20090264421Methods and Compositions for Treating Cancer
Compositions and methods for treating cancer, including hematologic cancers such as multiple myeloma, are disclosed. In some embodiments, chaetocin, chaetomin, or gliotoxin can be used to treat or ameliorate one or more symptoms or disorders associated with multiple mye...
10/22/2009
20090253687Fused Heterocyclic Compounds and Their Use as Mineralocorticoid Receptor Ligands
The present invention relates to wherein each symbol is as defined in the specification. The compound has a superior mineral corticoidreceptorantagonistic action and is useful as an agent for the prophylaxis or treatment of hypertension, cardiac failure and the like, a ...
10/08/2009
20090215754METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC AND ADDICTIVE DISORDERS
The present invention relates to methods and compositions for treating neuropathic pain and neuropsychiatric disorders by administering agents that are effective in reducing the effective amount, inactivating, and/or inhibiting the activity of a Na+—K+...
08/27/2009
20090163480Modified amino acids, pharmaceuticals containing these compounds and method for their production
The present invention relates to modified amino acids of general formula

wherein
A, Z, X, n, m, R, R2, R3, R4 and R11 are defined as in claims 1 to ...

06/25/2009
20090042868Indoleamine 2,3-Dioxygenase (IDO) Inhibitors
Inhibitors of indoleamine 2,3-dioxygenase (IDO) are provided as are pharmaceutical compositions containing such inhibitors as well as the use of such inhibitors and compositions for the treatment of a condition in a mammalian subject characterized by pathology of the ID...
02/12/2009
20090029974Tumor Treatment with Gliotoxin Derivatives
The present invention describes the use of Notch2 inhibitors for producing a medicament for the treatment of tumours, which tumours are characterised by ligand-independent Notch2 fragments....
01/29/2009
20080255100INDOLE ACETIC ACIDS EXHIBITING CRTH2 RECEPTOR ANTAGONISM AND USES THEREOF
The invention relates to indole acetic acid compounds which function as antagonists of the CRTH2 receptor. The invention also relates to the use of these compounds to inhibit the binding of prostaglandin D2 and its metabolites or certain thromboxane metabolit...
10/16/2008
20080255099Use of Diketodithiopiperazine Antibiotics for the Preparation of Antiangiogenic Pharmaceutical Compositions
The invention relates to the use of diketodithiopiperazine antibiotics, in particular chaetocin and gliotoxin, for the preparation of pharmaceutical compositions for antitumor therapy....
10/16/2008
20080214528ANTI-INFECTIVE AGENTS
The present invention provides HCV polymerase inhibiting compounds having the formula (I):

where R1 is cyclobutyl—N(Ra)-, n is 1, 2, 3 or 4, and at least one R5 is Ra

09/04/2008
20080193413Anti-Infective Agents
Compounds having the formula

are hepatitis C(HCV) polymerase inhibitors. Also disclosed are a composition and method for inhibiting hepatitis C(HCV) polymerase, processes for making the compounds, and synthet...

08/14/2008
20080176830Compounds, Compositions, and Methods
Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed....
07/24/2008
20080171737CYCLIC SULFONAMIDE DERIVATIVES AND METHODS OF THEIR USE
The present invention is directed to cyclic sulfonamide derivatives of formula I:

or a pharmaceutically acceptable salt thereof, which are monoamine reuptake inhibitors, compositions containing these derivati...

07/17/2008
20080161295SUBSTITUTED BENZOTHIADIAZINEDIOXIDE DERIVATIVES AND METHODS OF THEIR USE
The present invention is directed to substituted benzothiadiazinedioxide derivatives of formula I:

or a pharmaceutically acceptable salt, stereoisomer or tautomer thereof, which are monoamine reuptake inhibit...

07/03/2008
20080027043PREPARATION OF ANTIMICROBIAL FORMULATIONS USING 7-OXA-2-THIA-1,5-DIAZABICYCLO[3.3.1]NONANE-2,2-DIONE
Use of 7-oxa-2-thia-1,5-diazabicyclo[3.3.1]nonane-2,2-dione (“cyclotaurolidin”) for the preparation of antimicrobial formulations, in particular antimicrobial solutions for technical or medical purposes and of aqueous lock solutions for catheters and port systems fo...
01/31/2008
 
Sign InRegister
Username  
Password   
forgot password?